HighVista Strategies LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 83 filers reported holding RELMADA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$91,784
-91.8%
26,299
-12.5%
0.05%
-91.5%
Q3 2022$1,113,000
+98.8%
30,063
+1.9%
0.64%
+88.2%
Q2 2022$560,000
-2.9%
29,493
+37.9%
0.34%
-7.9%
Q1 2022$577,000
-19.9%
21,381
-4.8%
0.37%
-20.2%
Q4 2020$720,000
+52.2%
22,450
+78.7%
0.46%
+33.3%
Q3 2020$473,000
+9.0%
12,565
+29.6%
0.34%
-3.9%
Q2 2020$434,0009,6930.36%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders